NMJn
NMJn, also known as N-methyl-D-aspartate (NMDA) receptor antagonist, is a class of drugs used primarily in the treatment of neurological disorders. These drugs work by blocking the NMDA receptors, which are a type of ion channel found on neurons. By inhibiting these receptors, NMJn drugs can reduce the excitability of neurons, thereby modulating neurotransmission and potentially alleviating symptoms of various conditions.
NMJn drugs are commonly used in the management of epilepsy, particularly in cases where other antiepileptic
The most well-known NMJn drug is memantine, which is approved for the treatment of moderate to severe
NMJn drugs are typically administered orally or intravenously, depending on the specific condition being treated. They
In summary, NMJn drugs are a valuable tool in the management of various neurological disorders. Their mechanism